Overview
Chronic enteropathy associated with SLCO2A1 gene (also known as CEAS or chronic nonspecific multiple ulcers of the small intestine, CNSU) is a rare inherited digestive disorder caused by mutations in the SLCO2A1 gene. This gene provides instructions for making a protein that helps transport prostaglandins, which are important chemical messengers involved in inflammation and tissue repair in the gut lining. When this transporter does not work properly, prostaglandins build up in the intestinal wall, leading to chronic inflammation and the formation of multiple ulcers, primarily in the small intestine. Patients typically experience persistent or recurring abdominal pain, chronic diarrhea, blood in the stool, and iron-deficiency anemia that does not respond well to standard treatments. Over time, the ongoing blood loss and poor nutrient absorption can lead to significant weight loss, fatigue, and protein deficiency. Some patients may also develop thickening of the fingers (digital clubbing) and small bowel strictures that can cause intestinal obstruction. There is currently no cure for this condition. Treatment focuses on managing symptoms, correcting anemia with iron supplements or transfusions, ensuring adequate nutrition, and sometimes using medications to reduce inflammation. In severe cases where strictures or blockages develop, surgery may be needed to remove damaged sections of the intestine. The condition was initially described predominantly in East Asian populations, particularly in Japan, though cases have been identified in other regions as well.
Also known as:
Key symptoms:
Chronic or recurring abdominal painPersistent diarrheaBlood in the stool (visible or hidden)Iron-deficiency anemia that does not improve with standard treatmentUnexplained weight lossChronic fatigue and weaknessLow protein levels in the blood (hypoalbuminemia)Swelling in the legs or feet due to low proteinThickening or clubbing of the fingertipsMultiple small intestine ulcersNarrowing of the small intestine (strictures)Episodes of intestinal blockagePoor appetiteNausea
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Chronic enteropathy associated with SLCO2A1 gene.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Chronic enteropathy associated with SLCO2A1 gene at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Chronic enteropathy associated with SLCO2A1 gene.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesCuvposa
Shionogi, Inc.
Cuvposa — Contact Shionogi, Inc.
Travel Grants
No travel grants are currently matched to Chronic enteropathy associated with SLCO2A1 gene.
Community
No community posts yet. Be the first to share your experience with Chronic enteropathy associated with SLCO2A1 gene.
Start the conversation →Latest news about Chronic enteropathy associated with SLCO2A1 gene
No recent news articles for Chronic enteropathy associated with SLCO2A1 gene.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What is the current severity of my intestinal disease, and how many ulcers or strictures are present?,How often should I have blood tests and imaging to monitor my condition?,What are the best options for managing my anemia and nutritional deficiencies?,Are there any new or experimental treatments being studied for this condition?,What warning signs should prompt me to seek emergency care?,Should my family members be tested for carrier status of the SLCO2A1 gene mutation?,What dietary changes can help me manage my symptoms and improve my nutrition?
Common questions about Chronic enteropathy associated with SLCO2A1 gene
What is Chronic enteropathy associated with SLCO2A1 gene?
Chronic enteropathy associated with SLCO2A1 gene (also known as CEAS or chronic nonspecific multiple ulcers of the small intestine, CNSU) is a rare inherited digestive disorder caused by mutations in the SLCO2A1 gene. This gene provides instructions for making a protein that helps transport prostaglandins, which are important chemical messengers involved in inflammation and tissue repair in the gut lining. When this transporter does not work properly, prostaglandins build up in the intestinal wall, leading to chronic inflammation and the formation of multiple ulcers, primarily in the small int
How is Chronic enteropathy associated with SLCO2A1 gene inherited?
Chronic enteropathy associated with SLCO2A1 gene follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
What treatment and support options exist for Chronic enteropathy associated with SLCO2A1 gene?
1 patient support program are currently tracked on UniteRare for Chronic enteropathy associated with SLCO2A1 gene. See the treatments and support programs sections for copay assistance, eligibility, and contact details.